作者观察有哮喘症状,发病时 FEV_1下降>15%或使用支气管扩张药物效果良好的哮喘患儿共346例,平均年龄8.2岁(11个月～12岁).第1组81例,平均6.6岁,发病时喷吸二丙酸氯地米松(BDP)治疗,200～800μg/d(15μg/kg);第2组249例,平均10.9岁,哮喘发作时用其它非激素药物治疗,设为对照组;第3组16例,开始采用 BDP 治疗前、后作对照比较.以 Tunner-Whitehouse 标准衡量儿童 The authors observed an asthma symptom onset at onset FEV_1 decreased> 15% or bronchodilator with good results in children with a total of 346 cases of children with an average age of 8.2 years (11 months to 12 years) .Intervention group of 81 cases, an average of 6.6 years (BDP), 200 ~ 800μg / d (15μg / kg) was sprayed on onset. Group 2 (249 cases, average 10.9 years old) was treated with other non-hormonal drugs when the asthma attack was made as control Group, 16 cases in group 3 were compared before and after treatment with BDP, and children were evaluated according to the criteria of Tunner-Whitehouse